ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $235,000 | -11.3% | 17,247 | +8.6% | 0.27% | +34.0% |
| Q3 2018 | $265,000 | -29.5% | 15,886 | -33.2% | 0.20% | -33.2% |
| Q2 2018 | $376,000 | -0.5% | 23,796 | -20.1% | 0.30% | -25.5% |
| Q1 2018 | $378,000 | +116.0% | 29,779 | +94.7% | 0.41% | +73.6% |
| Q2 2017 | $175,000 | -61.5% | 15,296 | -29.9% | 0.24% | -57.5% |
| Q1 2017 | $454,000 | -65.7% | 21,805 | -65.7% | 0.55% | -68.4% |
| Q4 2016 | $1,322,000 | -3.9% | 63,571 | +51.5% | 1.75% | -14.0% |
| Q3 2016 | $1,375,000 | -26.6% | 41,960 | -44.1% | 2.04% | -33.5% |
| Q2 2016 | $1,873,000 | +9.7% | 75,002 | +7.5% | 3.06% | +10.1% |
| Q1 2016 | $1,708,000 | +40.7% | 69,742 | +89.7% | 2.78% | +39.7% |
| Q4 2015 | $1,214,000 | +61.7% | 36,756 | +60.3% | 1.99% | +75.4% |
| Q3 2015 | $751,000 | -21.9% | 22,925 | +26.4% | 1.14% | -16.0% |
| Q2 2015 | $961,000 | +344.9% | 18,133 | +144.3% | 1.35% | +1435.2% |
| Q4 2014 | $216,000 | -28.0% | 7,422 | -68.6% | 0.09% | -20.0% |
| Q3 2014 | $300,000 | -46.4% | 23,660 | -15.2% | 0.11% | -1.8% |
| Q2 2014 | $560,000 | – | 27,893 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |